105 related articles for article (PubMed ID: 20729158)
1. Variation in performance in low-volume mammography screening programmes: experience from Switzerland.
Bulliard JL; Ducros C; Dayer E; Arzel B; Levi F
Cancer Epidemiol; 2011 Jun; 35(3):293-7. PubMed ID: 20729158
[TBL] [Abstract][Full Text] [Related]
2. [Economic approach to breast cancer screening in Belgium].
Grivegnée AR; Autier P
Rev Med Brux; 2001 Sep; 22(4):A277-81. PubMed ID: 11680188
[TBL] [Abstract][Full Text] [Related]
3. Reattendance in the Swiss mammography screening pilot programme.
Bulliard JL; De Landtsheer JP; Levi F
J Med Screen; 2004; 11(2):59-64. PubMed ID: 15153319
[TBL] [Abstract][Full Text] [Related]
4. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Quality assured Mamma Diagnostic (QuaMaDi) programme on survival of breast cancer patients.
Obi N; Waldmann A; Schäfer F; Schreer I; Katalinic A
Cancer Epidemiol; 2011 Jun; 35(3):286-92. PubMed ID: 20920901
[TBL] [Abstract][Full Text] [Related]
6. [Organized screening for breast cancer: the Vaud experience].
De Landtsheer JP; Delaloye JF; Hessler C; De Grandi P; Paccaud F; Levi F
Rev Med Suisse Romande; 2000 Jun; 120(6):501-10. PubMed ID: 11014094
[No Abstract] [Full Text] [Related]
7. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres.
Törnberg S; Codd M; Rodrigues V; Segnan N; Ponti A
J Med Screen; 2005; 12(1):43-9. PubMed ID: 15814019
[TBL] [Abstract][Full Text] [Related]
8. [Danish Quality Database for Mammography Screening].
Vejborg I; Mikkelsen EM; Schwartz W; Bak M; Lernevall A; Borg Mogensen N; Garne JP
Ugeskr Laeger; 2012 Oct; 174(42):2533. PubMed ID: 23079436
[No Abstract] [Full Text] [Related]
9. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
10. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
11. Predicting the risk of a false-positive test for women following a mammography screening programme.
Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
[TBL] [Abstract][Full Text] [Related]
12. [Mammographic screening fulfills the requirements of health control].
Sandelin K
Lakartidningen; 1999 Mar; 96(9):983-4. PubMed ID: 10093435
[No Abstract] [Full Text] [Related]
13. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
14. Assessment of a breast cancer screening programme in Shiraz, Islamic Republic of Iran.
Hadi N; Sadeghi-Hassanabadi A; Talei AR; Arasteh MM; Kazerooni T
East Mediterr Health J; 2002; 8(2-3):386-92. PubMed ID: 15339128
[TBL] [Abstract][Full Text] [Related]
15. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
[TBL] [Abstract][Full Text] [Related]
16. [1989 Basel Mammography Action].
Laffer U; Almendral AC; Benz UF; Burckhardt B; Duplain H; Gaudenz R; Grosjean M; Marugg S; Marx A; Nidecker A
Helv Chir Acta; 1992 May; 59(1):203-8. PubMed ID: 1526829
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of mammography intervention in insured very low-income women.
Ahmed NU; Haber G; Semenya KA; Hargreaves MK
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1790-8. PubMed ID: 20587669
[TBL] [Abstract][Full Text] [Related]
18. [European recommendations for quality assurance in the setting of mammographic screening for breast cancer. Report of pathologists of the working group "Breast Cancer Screening" of the European Union].
Ann Pathol; 1996 Nov; 16(5):315-33. PubMed ID: 9004719
[No Abstract] [Full Text] [Related]
19. The public's response to the U.S. Preventive Services Task Force's 2009 recommendations on mammography screening.
Squiers LB; Holden DJ; Dolina SE; Kim AE; Bann CM; Renaud JM
Am J Prev Med; 2011 May; 40(5):497-504. PubMed ID: 21496748
[TBL] [Abstract][Full Text] [Related]
20. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
